Khalid Iqbal
Department of Neurochemistry New York State Institute for Basic Research in Developmental Disabilities
Forest Hill Road
Staten Island
New York
USA
Name/email consistency: high
- Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. Iqbal, K., Grundke-Iqbal, I. J. Cell. Mol. Med. (2008)
- Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly. Iqbal, K., Alonso, A.C., Grundke-Iqbal, I. J. Alzheimers Dis. (2008)
- Developing pharmacological therapies for Alzheimer disease. Iqbal, K., Grundke-Iqbal, I. Cell. Mol. Life Sci. (2007)
- Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective. Iqbal, K., Grundke-Iqbal, I. J. Alzheimers Dis. (2006)
- From tangles to tau protein. Iqbal, K., Novak, M. Bratisl. Lek. Listy (2006)
- Tau pathology in Alzheimer disease and other tauopathies. Iqbal, K., Alonso, A.C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.X., Khatoon, S., Li, B., Liu, F., Rahman, A., Tanimukai, H., Grundke-Iqbal, I. Biochim. Biophys. Acta (2005)
- Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies. Iqbal, K., Grundke-Iqbal, I. Acta Neuropathol. (2005)
- Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Iqbal, K., Flory, M., Khatoon, S., Soininen, H., Pirttila, T., Lehtovirta, M., Alafuzoff, I., Blennow, K., Andreasen, N., Vanmechelen, E., Grundke-Iqbal, I. Ann. Neurol. (2005)
- Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies. Iqbal, K., Grundke-Iqbal, I. Curr. Drug. Targets (2004)
- Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays. Iqbal, K., Alonso, A.C., El-Akkad, E., Gong, C.X., Haque, N., Khatoon, S., Pei, J.J., Tanimukai, H., Tsujio, I., Wang, J.Z., Grundke-Iqba, I. J. Mol. Neurosci. (2003)
